| 1 |
Ponziani FR, Nesci A, Caputo C, Salvatore L, Picca A, Del Chierico F, Paroni Sterbini F, Marzetti E, Di Giorgio A, Santoro L, Putignani L, Gasbarrini A, Santoliquido A, Pompili M. High prevalence of lower limb atherosclerosis is linked with the gut-liver axis in patients with primary biliary cholangitis. Liver Int 2023;43:370-80. [PMID: 36287108 DOI: 10.1111/liv.15463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Liu X, Han L, Bi S, Ding X, Sheng Q, Jiang Y, Guan G, Niu Q, Jing X. Differential metabolites in cirrhotic patients with hepatitis B and muscle mass loss. Front Nutr 2023;10:1068779. [PMID: 36875836 DOI: 10.3389/fnut.2023.1068779] [Reference Citation Analysis]
|
| 3 |
Strasser B, Ticinesi A. Intestinal microbiome in normal ageing, frailty and cognition decline. Curr Opin Clin Nutr Metab Care 2023;26:8-16. [PMID: 36102345 DOI: 10.1097/MCO.0000000000000878] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Almeida HM, Sardeli AV, Conway J, Duggal NA, Cavaglieri CR. Comparison between frail and non-frail older adults' gut microbiota: A systematic review and meta-analysis. Ageing Res Rev 2022;82:101773. [PMID: 36349647 DOI: 10.1016/j.arr.2022.101773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Schifano E, Conta G, Preziosi A, Ferrante C, Batignani G, Mancini P, Tomassini A, Sciubba F, Scopigno T, Uccelletti D, Miccheli A. 2-hydroxyisobutyric acid (2-HIBA) modulates ageing and fat deposition in Caenorhabditis elegans. Front Mol Biosci 2022;9. [DOI: 10.3389/fmolb.2022.986022] [Reference Citation Analysis]
|
| 6 |
Ponziani FR, Sacco M, Tardugno M, Santopaolo F, Marsico A, Manna S, Lancellotti S, Gasbarrini A, De Cristofaro R, Pompili M. Low ADAMTS-13/VWF ratio and altered gut–liver axis predict complications of advanced chronic liver disease: a pilot study. Gastroenterology Report 2022;10. [DOI: 10.1093/gastro/goac065] [Reference Citation Analysis]
|
| 7 |
Coelho-Júnior HJ, Picca A, Calvani R, Marzetti E. Prescription of resistance training for sarcopenic older adults: Does it require specific attention? Ageing Res Rev 2022;81:101720. [PMID: 35987322 DOI: 10.1016/j.arr.2022.101720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Zhang T, Cheng JK, Hu YM. Gut microbiota as a promising therapeutic target for age-related sarcopenia. Ageing Res Rev 2022;81:101739. [PMID: 36182084 DOI: 10.1016/j.arr.2022.101739] [Reference Citation Analysis]
|
| 9 |
Lee PC, Lee KC, Yang TC, Lu HS, Cheng TY, Chen YJ, Chiou JJ, Huang CW, Yang UC, Chia-Hui Tan E, Chou SH, Kuo YL, Schnabl B, Huang YH, Hou MC. Sarcopenia-related gut microbial changes are associated with the risk of complications in people with cirrhosis. JHEP Rep 2023;5:100619. [PMID: 36536957 DOI: 10.1016/j.jhepr.2022.100619] [Reference Citation Analysis]
|
| 10 |
Lee YA, Song SW, Jung SY, Bae J, Hwang N, Kim HN. Sarcopenia in community-dwelling older adults is associated with the diversity and composition of the gut microbiota. Exp Gerontol 2022;167:111927. [PMID: 35981616 DOI: 10.1016/j.exger.2022.111927] [Reference Citation Analysis]
|
| 11 |
Wang B, Li H, Li Z, Wang B, Zhang H, Zhang B, Luo H. Integrative network analysis revealed the molecular function of folic acid on immunological enhancement in a sheep model. Front Immunol 2022;13:913854. [DOI: 10.3389/fimmu.2022.913854] [Reference Citation Analysis]
|
| 12 |
Kuchay MS, Martínez-Montoro JI, Kaur P, Fernández-García JC, Ramos-Molina B. Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk. Ageing Res Rev 2022;80:101696. [PMID: 35843589 DOI: 10.1016/j.arr.2022.101696] [Reference Citation Analysis]
|
| 13 |
Maslennikov R, Ivashkin V, Alieva A, Poluektova E, Kudryavtseva A, Krasnov G, Zharkova M, Zharikov Y. Gut dysbiosis and body composition in cirrhosis. World J Hepatol 2022;14:1210-25. [PMID: 35978666 DOI: 10.4254/wjh.v14.i6.1210] [Reference Citation Analysis]
|
| 14 |
Mohammadzadeh R, Mahnert A, Duller S, Moissl-eichinger C. Archaeal key-residents within the human microbiome: characteristics, interactions and involvement in health and disease. Current Opinion in Microbiology 2022;67:102146. [DOI: 10.1016/j.mib.2022.102146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Yamamoto K, Ishizu Y, Honda T, Ito T, Imai N, Nakamura M, Kawashima H, Kitaura Y, Ishigami M, Fujishiro M. Patients with low muscle mass have characteristic microbiome with low potential for amino acid synthesis in chronic liver disease. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07810-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Daily JW, Park S. Sarcopenia Is a Cause and Consequence of Metabolic Dysregulation in Aging Humans: Effects of Gut Dysbiosis, Glucose Dysregulation, Diet and Lifestyle. Cells 2022;11:338. [DOI: 10.3390/cells11030338] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 17 |
Jiang L, Fei H, Tong J, Zhou J, Zhu J, Jin X, Shi Z, Zhou Y, Ma X, Yu H, Yang J, Zhang S. Hormone Replacement Therapy Reverses Gut Microbiome and Serum Metabolome Alterations in Premature Ovarian Insufficiency. Front Endocrinol (Lausanne) 2021;12:794496. [PMID: 35002971 DOI: 10.3389/fendo.2021.794496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Okubo H, Ando H, Nakadera E, Ikejima K, Shiina S, Nagahara A. Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis. Nutrients 2021;13:4428. [PMID: 34959980 DOI: 10.3390/nu13124428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Prokopidis K, Chambers E, Ni Lochlainn M, Witard OC. Mechanisms Linking the Gut-Muscle Axis With Muscle Protein Metabolism and Anabolic Resistance: Implications for Older Adults at Risk of Sarcopenia. Front Physiol 2021;12:770455. [PMID: 34764887 DOI: 10.3389/fphys.2021.770455] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 20 |
Cerreto M, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut-Liver Axis. Nutrients 2021;13:2649. [PMID: 34444807 DOI: 10.3390/nu13082649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 21 |
Nishikawa H, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Sarcopenia and Frailty in Liver Cirrhosis. Life (Basel) 2021;11:399. [PMID: 33925660 DOI: 10.3390/life11050399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
